About Us
Heat Biologics is a clinical-stage company focused on developing its proprietary ImPACT (Immune Pan-Antigen Cytotoxic Therapy) technology platform to treat cancers and infectious diseases. Our goal is to provide a safe and affordable, off-the-shelf therapy for patients with both early and advanced stages of cancer.
|
|
 |
ImPACT Technology
Heat Biologics’ ImPACT (Immune Pan-Antigen Cytotoxic Therapy) is a first-in-class fully-human adjuvant technology that specifically stimulates the tumor cell-killing arm of the immune system toward the specific ‘fingerprint’ of a particular cancer. We are currently in Phase II Clinical Trials for patients with non-small cell lung cancer and will be initiating clinical trials in bladder cancer in mid-2012.
 |
|
|
|
